retatrutide status fda Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Retatrutide FDA Approval Status 2026:

Can anxiety about taking the pill make my throat tighter

Here are the most common issues people encounter with compounded semaglutide with B12 and how to handle them

Call 999 or go to your nearest emergency department immediately if: You experience sudden, severe dizziness with loss of balance, difficulty speaking, facial drooping, or weakness in the limbs these may be signs of a stroke and require immediate assessment You faint or lose consciousness You experience chest pain or severe shortness of breath alongside dizziness For those participating in a clinical trial, all adverse events including dizziness should be reported to the trial team in accordance with the study protocol, regardless of perceived severity

This shift has even earned a name: the "Ozempic smell" phenomenon a term gaining traction to describe the growing number of users who find themselves repelled by everyday scents or drawn, unexpectedly, to dessert-like, nostalgic aromas

Trials: Expected to commence in late 2026 or early 2027

Both the lyophilized powder and the reconstituted solution should be protected from direct light